Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
pharma news today glp-1 obesity drug updates Three drugs. Three mechanisms. Zero clarity on who pays. ADA 2026 just compressed the next-gen obesity pipeline into a single week. → Zealand + Roche unveiled their amylin agonist play — Binders Flavor:The Summer Body Set Addressing GLP-1 Access and
Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions
California Anthem Blue Cross in California administers Medi-Cal managed care plans that have ended all GLP-1 weight loss coverage
Binders
Flavor:The Summer Body Set
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial
US$ 29.77
US$ 24.81
US$ 26.68
